“ 정보이용료현금ᐲ 【캬툑R2222】【달봉티켓】 boston정보이용료현금さ콘텐츠이용료현금last 구글결제현금화⒬소액결제정책ⓞ소액결제대행사ｌａ핸드폰결제현금화descent”的搜索结果，显示 271-280 项，共有 12857 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... information about patients, treatments, and the behavior of the underlying cancer. Research involving biospecimens that are linked to related medical ...

4. 妙佑医疗国际 - 褪黑素

   盲人昼夜节律性睡眠障碍。褪黑素可以帮助改善成人和儿童的这类障碍。 睡眠时相延迟（延迟睡眠觉醒阶段睡眠障碍）。出现这种障碍时 ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...